Two patented technologies for the treatment of dry eye
CHE COS’E’ L’OCCHIO SECCO
Intense Pulsed Light (IPL) is an insufficient technology for the treatment of the Meibomian Glands Dysfunction (MGD). Following years of research, Espansione Group has developed an innovative device for the treatment of MGD, and other related pathologies, that is radically different from existing treatments.
EYE-LIGHT LINE RESOLVES THE IPL LIMITATIONS
The IPL can be only applied to the lower eyelids. This implies that the Meibomian Glands located in the upper eyelid could not be treated.
Thanks to combined therapy and innovative design, the treatment of both, upper and lower meibomian glands is now possible. In addition, Eye-light allows us to treat other frequent related pathologies, such as chalazion, stye, blepharitis, post-blepharoplasty, demodex and dry eye caused by refractive and cataract surgery.
OPTIMAL POWER ENERGY - (IPL)
he first step of the treatment consists of just 5 painless light shots (OPEⓇ / IPL) around the eye and on the inferior eyelid. This makes blood to flow better, dissipates blood vessels and improves the secretion of anti-inflammatory cytokines.
• No gel required
• Totally automated
• Updatable software
• Other ophthalmic treatments
LIGHT MODULATION ®
LLLT – LOW LEVEL LIGHT THERAPY
LIGHT MODULATION® treats directly the Meibomian glands, triggering an endogenous heating of both eyelids. This patented photobiomodulation technology triggers cell ATP production and so eyelids endogenous heat.Thanks to the light emission of LED matrix, the tear lipid layer is increased and stabilized.